Psyence Biomedical Ltd Common Shares
Quarterly Financials
| Values in thousands | 2025-09-30 | 2024-09-30 |
|---|---|---|
Revenue | $0 | $0 |
Gross Profit | -1 | |
EBITDA | -749 | |
EBIT | -750 | -1,157 |
Net Income | -753 | 141 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | ||
Cash | 7,197 | 1,932 |
Basic Shares | 1,481 | 76 |
Annual Financials
| Values in thousands | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -4 | |||
EBITDA | 1,025 | -51,105 | -1,293 | -334 |
EBIT | 1,021 | -51,106 | -1,293 | -334 |
Net Income | 1,011 | -51,159 | 8,014 | 8,230 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,744 | -2,951 | -519 | -839 |
Cash | 6,135 | 762 | 128 | 648 |
Basic Shares | 568 | 6,517 | 32,674 | 32,674 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.51 |
2025-03-31 | -$99.97 |
2024-12-31 | $4.06 |
2024-09-30 | $4.07 |
